A 1 LEU 16 -16.143 -16.127
A 2 THR 15 -18.229 -17.857
A 3 GLU 9 -19.091 -17.931
A 4 TYR 24 -21.455 -21.748
A 5 THR 11 -21.465 -20.261
A 6 LEU 36 -22.472 -24.027
A 7 GLN 9 -19.916 -18.661
A 8 ALA 28 -19.444 -20.428
A 9 ASN 7 -15.911 -14.886
A 10 TRP 3 -13.732 -12.498
A 11 PHE 5 -13.004 -12.084
A 12 ASP 25 -16.650 -17.610
A 13 ILE 15 -17.495 -17.208
A 14 THR 1 -14.963 -13.357
A 15 GLY 17 -17.255 -17.225
A 16 ILE 30 -20.539 -21.627
A 17 LEU 9 -18.696 -17.581
A 18 TRP 8 -16.404 -15.437
A 19 LEU 28 -19.431 -20.417
A 20 LEU 24 -19.861 -20.337
A 21 GLY 6 -16.178 -15.007
A 22 GLN 13 -15.508 -15.220
A 23 VAL 26 -17.276 -18.280
A 24 ASP 6 -15.627 -14.520
A 25 GLY 33 -18.915 -20.535
A 26 LYS 2 -18.279 -16.407
A 27 ILE 18 -18.892 -18.790
A 28 ILE 13 -16.955 -16.500
A 29 ASN 9 -15.465 -14.722
A 30 SER 15 -15.717 -15.634
A 31 ASP 9 -14.308 -13.697
A 32 VAL 4 -13.112 -12.064
A 33 GLN 6 -11.117 -10.528
A 34 ALA 0 -10.306 -9.121
A 35 PHE 10 -14.875 -14.314
A 36 VAL 18 -17.674 -17.711
A 37 LEU 9 -19.126 -17.962
A 38 LEU 26 -21.320 -21.859
A 39 ARG 9 -20.525 -19.200
A 40 VAL 32 -21.817 -22.988
A 41 ALA 8 -20.178 -18.778
A 42 LEU 27 -20.079 -20.875
A 43 PRO 10 -16.879 -16.088
A 44 ALA 0 -16.410 -14.523
A 45 ALA 3 -15.069 -13.681
A 46 LYS 19 -17.467 -17.643
A 47 VAL 18 -19.589 -19.406
A 48 ALA 1 -18.057 -16.095
A 49 GLU 13 -17.627 -17.095
A 50 PHE 31 -20.690 -21.876
A 51 SER 13 -20.599 -19.725
A 52 ALA 6 -18.394 -16.969
A 53 LYS 17 -18.585 -18.403
A 54 LEU 27 -21.094 -21.773
A 55 ALA 10 -18.663 -17.667
A 56 ASP 7 -15.331 -14.373
A 57 PHE 23 -17.102 -17.781
A 58 SER 22 -17.155 -17.712
A 59 GLY 3 -13.627 -12.405
A 60 GLY 0 -15.800 -13.983
A 61 SER 12 -16.159 -15.680
A 62 LEU 32 -20.145 -21.508
A 63 GLN 3 -20.645 -18.615
A 64 LEU 26 -22.311 -22.735
A 65 LEU 11 -20.523 -19.428
A 66 ALA 6 -18.797 -17.326
A 67 ILE 15 -17.167 -16.918
A 68 GLU 0 -12.649 -11.194

Identified 0 B-Cell epitope residues out of 68 total residues